Emerson Electric on Pace for Largest Percent Increase Since June 2022 — Data Talk
Emerson Electric Co. (EMR) is currently at $95.82, up $4.19 or 4.57%
--Would be highest close since Jan. 13, 2023, when it closed at $97.92
--On pace for largest percent increase since June 24, 2022, when it rose 5.45%
--Currently up three consecutive days; up 5.33% over this period
--Best three day stretch since the three days ending June 5, 2023, when it rose 5.81%
--Down 0.26% year-to-date
--Down 9.35% from its all-time closing high of $105.70 on Sept. 2, 2021
--Up 6.67% from 52 weeks ago (Aug. 3, 2022), when it closed at $89.82
--Down 2.43% from its 52-week closing high of $98.20 on Jan. 11, 2023
--Up 31.15% from its 52-week closing low of $73.06 on Sept. 27, 2022
--Traded as high as $98.54; highest intraday level since Jan. 12, 2023, when it hit $99.28
--Up 7.54% at today's intraday high; largest intraday percent increase since Nov. 9, 2020, when it rose as much as 10.61%
--Seventh best performer in the S&P 500 today
All data as of 10:29:44 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 02, 2023 10:46 ET (14:46 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization